Skip to content
DraconiticResearch
Search Sources API
197,787 studies31 sourcesUpdated 10 min ago
Peer-reviewedCC BY-NC-NDBMC surgery

Study on the migration of bacteria in transoral endoscopic thyroidectomy vestibular approach and development of a comprehensive oral management process.

  1. 1Department of Thyroid and Parathyroid Surgery, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
  2. 2Department of Thyroid and Parathyroid Surgery, The First Affiliated Hospital of Kunming Medical University, Kunming, China. [email protected].
  3. 3Department of Thyroid and Parathyroid Surgery, The First Affiliated Hospital of Kunming Medical University, Kunming, China. [email protected].

Abstract

Background

The transoral endoscopic thyroidectomy vestibular approach (TOETVA) utilizes an intraoral incision, raising concerns about surgical-site infections (SSI) originating from the oral cavity. The types and sources of bacteria that may cause TOETVA infection are not clear, and the optimal antibiotic prevention plan is still unclear, lacking targeted perioperative management.Materials and methods

In this prospective, non-randomized controlled experimental study, drainage-fluid from 52 TOETVA and 15 open surgery patients (March - December 2025) was analyzed using 16S rDNA sequencing and clinical review. TOETVA patients were allocated to three perioperative antibiotic regimens: preoperative cefuroxime (Group A, n = 18), postoperative cefuroxime (Group B, n = 16), or postoperative metronidazole (Group C, n = 18). Inclusion criteria were initial surgery for T1N0M0 papillary thyroid carcinoma, no prior neck radiation, and patient preference for a scar-free neck. The primary outcome was postoperative SSI rate. Secondary outcomes included changes in drainage-fluid bacterial abundance, pus culture results, effects of different oral cleaning protocols, and microbial correlation between drainage-fluid and disinfected neck skin or oral vestibule. Statistical analyses employed the Chi-Square test, Kruskal-Wallis test, and Spearman Correlation.Results

No SSI occurred in cefuroxime group, while two infections were recorded in the metronidazole group. Analysis of the top 30 differentially abundant bacterial species showed that cefuroxime reduced the abundance of 15/30 (50%) within 48 h, compared to only 4/30 (13.3%) with metronidazole (OR: 6.50, 95% CI: 1.90-22.26, P = 0.0023). Microbial composition in drainage-fluid strongly correlated with povidone-iodine-disinfected chin skin (ρ = 0.8195, 95% CI: 0.6865-0.8994, P < 0.001). However, pus cultures from infected cases grew oral streptococci, not skin flora. Among four oral cleaning regimens, povidone-iodine most effectively reduced streptococcal load, whereas tinidazole better preserved the overall microbiota balance.Conclusions

Although the drainage-fluid following TOETVA primarily reflects skin microbiota, clinical surgical-site infections are mainly attributed to oral streptococci. Cefuroxime provides superior perioperative antibacterial coverage compared to metronidazole. Based on clinical practice considerations, a comprehensive oral management process can be helpful for the treatment of TOETVA.Trial registration

Retrospectively registered in Chinese Clinical Trial Registry on April 8, 2026 (Registration number: ChiCTR2600122005).

Related

  1. Association of intraoperative mitoxantrone hydrochloride injection with incidental parathyroidectomy and parathyroid autotransplantation during gasless unilateral axillary endoscopic thyroidectomy: a propensity score-matched retrospective cohort study
    Qi Jiang, Yaozong Wang, Ziyan Wang +6
    Gland SurgeryPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  2. Transoral thyroidectomy in a consecutive cancer-enriched cohort of 1–000 patients: a single-surgeon experience with endoscopic and robotic platforms
    Nam Kyung Kim, Junu Kim, Jun Sung Lee +4
    Frontiers in endocrinologyPeer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMCCrossref
  3. Three-dimensional totally endoscopic quadruple procedure in a high-risk patient who is a Jehovah's Witness: A comprehensive bloodless strategy
    JTCVS techniquesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Development of a multi-parameter MRI-based habitat radiomics model for differential diagnosis of vestibular schwannoma and meningioma in the cerebellopontine angle: a multi-center study.
    Xiyuan Tang, Xueyun Deng, Yanfen Zhao +4
    BMC cancerPeer-reviewedCC BY-NC-NDFull textMedical imaging & radiologyEurope PMC
  5. Contemporary diagnosis and management of vestibular migraine: a systematic review of conventional and CGRP-targeted therapies
    Saleh Alabood, Laila Aldokhail, Enar Alotaibi +3
    Frontiers in NeurologyPeer-reviewedCC BY 4.0Full textPsychiatry & mental healthCrossref
BibTeX
@article{zhan2026study,
  title = {{Study on the migration of bacteria in transoral endoscopic thyroidectomy vestibular approach and development of a comprehensive oral management process.}},
  author = {Xiangxiang Zhan and Zhizhong Dong and Shiqi Wang and Tianyun Wen and Qiuyu Meng and Yanjun Su and Wen Liu and Ruochuan Cheng},
  journal = {BMC surgery},
  year = {2026},
  month = jul,
  doi = {10.1186/s12893-026-04084-8},
  url = {https://europepmc.org/article/MED/42907790},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Study on the migration of bacteria in transoral endoscopic thyroidectomy vestibular approach and development of a comprehensive oral management process.
AU  - Xiangxiang Zhan
AU  - Zhizhong Dong
AU  - Shiqi Wang
AU  - Tianyun Wen
AU  - Qiuyu Meng
AU  - Yanjun Su
AU  - Wen Liu
AU  - Ruochuan Cheng
PY  - 2026
DA  - 2026/07/01
JO  - BMC surgery
DO  - 10.1186/s12893-026-04084-8
UR  - https://europepmc.org/article/MED/42907790
AB  - Background  The transoral endoscopic thyroidectomy vestibular approach (TOETVA) utilizes an intraoral incision, raising concerns about surgical-site infections (SSI) originating from the oral cavity. The types and sources of bacteria that may cause TOETVA infection are not clear, and the optimal antibiotic prevention plan is still unclear, lacking targeted perioperative management.Materials and methods  In this prospective, non-randomized controlled experimental study, drainage-fluid from 52 TOETVA and 15 open surgery patients (March - December 2025) was analyzed using 16S rDNA sequencing and clinical review. TOETVA patients were allocated to three perioperative antibiotic regimens: preoperative cefuroxime (Group A, n = 18), postoperative cefuroxime (Group B, n = 16), or postoperative metronidazole (Group C, n = 18). Inclusion criteria were initial surgery for T1N0M0 papillary thyroid carcinoma, no prior neck radiation, and patient preference for a scar-free neck. The primary outcome was postoperative SSI rate. Secondary outcomes included changes in drainage-fluid bacterial abundance, pus culture results, effects of different oral cleaning protocols, and microbial correlation between drainage-fluid and disinfected neck skin or oral vestibule. Statistical analyses employed the Chi-Square test, Kruskal-Wallis test, and Spearman Correlation.Results  No SSI occurred in cefuroxime group, while two infections were recorded in the metronidazole group. Analysis of the top 30 differentially abundant bacterial species showed that cefuroxime reduced the abundance of 15/30 (50%) within 48 h, compared to only 4/30 (13.3%) with metronidazole (OR: 6.50, 95% CI: 1.90-22.26, P = 0.0023). Microbial composition in drainage-fluid strongly correlated with povidone-iodine-disinfected chin skin (ρ = 0.8195, 95% CI: 0.6865-0.8994, P < 0.001). However, pus cultures from infected cases grew oral streptococci, not skin flora. Among four oral cleaning regimens, povidone-iodine most effectively reduced streptococcal load, whereas tinidazole better preserved the overall microbiota balance.Conclusions  Although the drainage-fluid following TOETVA primarily reflects skin microbiota, clinical surgical-site infections are mainly attributed to oral streptococci. Cefuroxime provides superior perioperative antibacterial coverage compared to metronidazole. Based on clinical practice considerations, a comprehensive oral management process can be helpful for the treatment of TOETVA.Trial registration  Retrospectively registered in Chinese Clinical Trial Registry on April 8, 2026 (Registration number: ChiCTR2600122005).
SN  - 1471-2482
ER  -